Lv65
2180 积分 2021-07-20 加入
Remodeling cyclophilin A to target KRAS
1天前
已完结
Targeting cancer with small molecule pan-KRAS degraders
2天前
已完结
Pan-KRAS destruction with a single PROTAC
2天前
已完结
Beyond First-Generation KRAS Inhibitors: BBO-8520 Tests the Dual Mechanism Hypothesis
3天前
求助中
Challenges and Opportunities of Emerging Mechanisms of Resistance to KRASG12C Inhibitors
3天前
已关闭
Discovery of a Highly Potent and Selective Tyrosine Kinase 2 (TYK2) Degrader with In Vivo Therapeutic Efficacy in a Murine Psoriasis Model
4天前
已完结
Discovery of Novel Sulfonylurea NLRP3 Inflammasome Inhibitor for the Treatment of Multiple Inflammatory Diseases
4天前
已完结
Discovery of HM-279, a Potent Inhibitor of ALK5 for Improving Therapeutic Efficacy of Cancer Immunotherapy
4天前
已完结
UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor
4天前
已完结
Discovery of YJZ5118: A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt Inhibition
4天前
已完结
皖公网安备34019202002308
